EMA/PE/0000183329 - paediatric investigation plan

interleukin-23 receptor antagonist peptide

Key facts

• Active substance:
  interleukin-23 receptor antagonist peptide
• Therapeutic area:
  Dermatology
• Decision number:
  EMA/PE/0000183329
• PIP number:
  EMA/PE/0000183329
• Pharmaceutical form(s):
  • Age appropriate dosage form
  • Film-coated tablet
• Condition(s) / indication(s):
  Treatment of psoriasis
• Route(s) of administration:
  Oral use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  06/12/2024
• Compliance check done:
  No

Decision

EMA/PE/0000183329 : EMA decision of 6 December 2024 on the of a modification of an agreed paediatric investigation plan for interleukin-23 receptor antagonist peptide (JNJ-77242113)

Adopted Reference Number: EMADOC-1700519818-1793192